HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Menu
My View
  • Edit
  • Add your favourite topics for quick access
Meet the Team
Ask the Analyst
PDF Library
RSS Feeds
Subscribe
Advertising
Partnered Content
Report Store
UsernamePublicRestriction
Tags:
Regulation Dietary Supplements Manufacturing

Modernizing FDA's Supplement Industry Regulation Mapped Out In Five-Point Plan

  • News

Executive Summary

Commissioner Scott Gottlieb announces FDA's plan for policy changes to implement "one of the most significant modernizations of dietary supplement regulation and oversight in more than 25 years." Plan includes steps to ensure its regulatory framework is flexible enough to adequately evaluate product safety while also promoting innovation, particularly finalizing NDI notifications guidance and fostering submissions of the notifications.

Table

View full table

Advertisement

Related Content

HBW Insight
Budget Good For FDA Supplement Sector Oversight? Congress Wants To Know
HBW Insight
'Blood Disorders' Supplement, More Bocchi Labs Hair Care Products Recalled
HBW Insight
FDA To Consider Regulatory Shift Making Cannabis Ingredients Officially Eligible For Use In Dietary Supplements
HBW Insight
FDA Asks Whether Supplement Industry Has Outgrown Regulatory Framework
HBW Insight
Health, Beauty And Wellness News: Nestle Compleat, FDA Nutrition Strategy
HBW Insight
Compiling Pre-DSHEA Ingredient List Relies On Bridging FDA-Industry Gap
HBW Insight
Lack Of Supplement NDI Notification Guidance Not A Market Pass For Industry

Topics

Advertisement
Tags:
Regulation Dietary Supplements Manufacturing
UsernamePublicRestriction

Register

RS148527

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By